Moshe Szyf

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Moshe Szyf
Fields Epigenetics and Cancer research

Moshe Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology. He is one of the pioneers of epigenetics.

Szyf's main research interests lie with epigenetics, including behavioral epigenetics as well as cancer research.

Education and career[edit]

Szyf received his Ph.D. from the Hebrew University on basic mechanisms of DNA methylation under supervision of Aharon Razin. Subsequently he performed postdoctoral work at Harvard Medical School. In 1989, he was appointed as assistant professor in pharmacology and therapeutics at McGill University.[1]

Publications[edit]

Books
Articles

As of October 2013, Moshe Szyf more than 140 papers in peer-reviewed journals, almost all on epigenetics.[2]

Szyf also holds many patents, all relating to epigenetics-based therapeutics.[2]

References[edit]

  1. ^ Dr. Moshe Szyf, 6th International Conference on Genomics (ICG), 2011
  2. ^ a b Moshe Szyf, sickkids.ca

External links[edit]